Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin–doxorubicin sensitivity

This publication has 16 references indexed in Scilit:

• Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua
  Fertility and Sterility, 2003
• The Expression of hCG Receptor mRNA in Four Human Ovarian Cancer Cell Lines Varies Considerably under Different Experimental Conditions
  Tumor Biology, 2003
• Cytotoxic and Antitumor Activities of Doxorubicin Conjugates with the Epidermal Growth Factor and its Receptor-binding Fragment
  Journal of Drug Targeting, 2002
• Transcriptional Regulation of the Lutropin/Human Choriogonadotropin Receptor and Three Enzymes of Steroidogenesis by Growth Factors in Cultured Pig Leydig Cells
  European Journal of Biochemistry, 1996
• Induction of Ovarian Tumors by Endogenous Gonadotropins in Rats Bearing Intrasplenic Ovarian Grafts
  Tumor Biology, 1995
• Targeted approaches to cancer therapy: Meeting held at stone house, NIH, bethesda, md, January 11–12, 1993
  International Journal of Cancer, 1994
• Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1992
• Localization of the human luteinizing hormone/choriogonadotropin receptor gene (LHCGR) to chromosome 2p21
  Cytogenetic and Genome Research, 1990
• The induction of ovarian LH‐receptors by FSH is mediated by cyclic AMP
  FEBS Letters, 1981
• Development of Tumors in the Rat Ovary After Transplantation into the Spleen.
  Experimental Biology and Medicine, 1944